PaceMate provides a comprehensive cardiac data management platform and 24/7/365 clinical service solutions that integrate implantable devices, ambulatory monitors, consumer ECGs, and heart-failure products into a single cloud-native workflow. Its PaceMateLIVE dashboard and Auto-Triage™ prioritize patients using clinician-customized standards to reduce alert burden and streamline workflows. The company positions itself as a pioneer in cardiac remote monitoring and a market leader in electronic health record interoperability. Offerings include software-only, concierge on-demand, and full-service solutions tailored to cardiac practices. PaceMate reported a record year with revenues growing in excess of 100% while adding several top cardiac practices and health systems as customers. Leadership says the investment will help scale presence, expand the product portfolio, and deliver flexible solutions to more healthcare institutions. PaceMate offers PaceMateLIVE, a fully automated, bidirectional EHR-integrated, cloud-native software+service platform for real-time cardiac device management that supports clinics around the clock. The platform ingests device-generated data into a vendor-neutral system for immediate review, reporting clinically actionable alerts and automating billing codes. PaceMate emphasizes seamless workflow integration to reduce medical errors and streamline device-clinic operations. The company plans to use new capital to expand market reach and enable more hospital systems and device clinics to implement its platform more quickly. The announcement ties the product strategy to improved patient care and operational efficiency for cardiology clients. The company was founded in 2015 and is based in Bradenton, Fla.

Total raised

$8M

Funding rounds

2

Latest round

Series A

Latest activity

Mar 2021